Close
Close

Advanced Therapies Commercialisation Congress

3.0
3.1 from 29 votes
Date: 02 - 03 October, 2018
Location: Amsterdam, The Netherlands

Novel Strategies for Balancing Cost, Access and Quality for Next-Generation Therapies

CBI's Advanced Therapies Commercialisation Congress is a collaborative, multi-stakeholder meeting for exchanging views and exploring business approaches for the evolving ATMP segment. This congress convenes industry executives, public policy makers, academia and other professionals in the advanced therapies community to address the key barriers and exciting opportunities on the journey to commercialisation of these innovative technologies.


A Dialogue-Driven Forum on Key Issues and the Path Forward for Advanced Therapies:

Review significant recent and the expected upcoming events in the ATMP space
Weigh the pros and cons of EU-accelerated clinical development and market access pathways
Hear case studies from industry pioneers throughout the world
Draw insights from ATMPs that have been commercialised to date to inform future market access strategies
Anticipate what technologies and infrastructure will be needed in the future to mainstream ATMPs
Learn about recent pricing and reimbursement strategies for cell and gene therapies in the EU and US
Deliberate over the real-world challenges and approaches to defining and demonstrating therapy value

3.0
3.1 from 29 votes